Serum C-reactive protein levels and death and cardiovascular events in mild to moderate chronic kidney disease

International Heart Journal

Volumn 52, Issue 3, 2011, Pages 180-184

  Koeda, Yorihiko ^a   Nakamura, Motoyuki ^a   Tanaka, Fumitaka ^a   Onoda, Toshiyuki ^b   Itai, Kazuyoshi ^b   Tanno, Kozo ^b   Ohsawa, Masaki ^b   Makita, Shinji ^a   Ishibashi, Yasuhiro ^a   Koyama, Tomiko ^a   Yoshida, Yuki ^b   Omama, Shin Ichi ^b   Ogasawara, Kuniaki ^b   Ogawa, Akira ^b   Kuribayashi, Toru ^a   Okayama, Akira ^c  

^a IWATE UNIVERSITY   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c FUKUJUJI HOSPITAL   (Japan)

Author keywords

Mortality; Myocardial infarction; Prediction; Risk; Stroke

Indexed keywords

C REACTIVE PROTEIN; CREATININE;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STROKE;

AGED; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DISEASE-FREE SURVIVAL; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 79958750957     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.52.180     Document Type: Article

References (37)

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classifcation, and stratif-cation. Am J Kidney Dis 2002; 39: S1-S266.
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-305.
3. Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006; 17: 2034-47. (Review)
4. Weiner DE, Tighiouart H, Amin MG, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15: 1307-15.
5. Ninomiya T, Kiyohara Y, Kubo M, et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int 2005; 68: 228-36.
6. Nakamura K, Okamura T, Hayakawa T, et al. Chronic kidney disease is a risk factor for cardiovascular death in a community-based population in Japan: NIPPON DATA90. Circ J 2006; 70: 954-9.
7. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Infammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-9.
8. Tracy RP, Lemaitre RN, Psaty BM, et al. Relationship of C-reac-tive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997; 17: 1121-7.
9. Koenig W, Sund M, FrÖhlich M, et al. C-Reactive protein, a sensitive marker of infammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99: 237-42.
10. Yamada S, Gotoh T, Nakashima Y, et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi Medical School Cohort Study. Am J Epidemiol 2001; 153: 1183-90.
11. Nakamura M, Onoda T, Itai K, et al. Association between serum C-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan. Intern Med 2004; 43: 919-25.
12. Arima H, Kubo M, Yonemoto K, et al. High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study. Arterioscler Thromb Vasc Biol 2008; 28: 1385-91.
13. Wakugawa Y, Kiyohara Y, Tanizaki Y, et al. C-reactive protein and risk of first-ever ischemic and hemorrhagic stroke in a general Japanese population: the Hisayama Study. Stroke 2006; 37: 27-32.
14. Imai E, Horio M, Iseki K, et al. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modifed by a Japanese coeffcient. Clin Exp Ne-phrol 2007; 11: 156-63.
15. Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008; 8: 117. (Review)
16. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-47.
17. Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-92.
18. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakan-gas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994; 90: 583-612.
19. Makita S, Nakamura M, Satoh K, et al. Serum C-reactive protein levels can be used to predict future ischemic stroke and mortality in Japanese men from the general population. Atherosclerosis 2009; 204: 234-8.
20. Nagata M, Ninomiya T, Doi Y, et al. Trends in the prevalence of chronic kidney disease and its risk factors in a general Japanese population: the Hisayama Study. Nephrol Dial Transplant 2010; 25: 2557-64.
21. Makita S, Nakamura M, Hiramori K. The association of C-reac-tive protein levels with carotid intima-media complex thickness and plaque formation in the general population. Stroke 2005; 36: 2138-42.
22. Fox ER, Benjamin EJ, Sarpong DF, et al. The relation of C--reac-tive protein to chronic kidney disease in African Americans: the Jackson Heart Study. BMC Nephrol 2010; 11: 1.
23. Menon V, Wang X, Greene T, et al. Relationship between C-reac-tive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. Am J Kidney Dis 2003; 42: 44-52.
24. Soriano S, González L, Martin-Malo A, Rodríguez M, Aljama P. C-reactive protein and low albumin are predictors of morbidity and cardiovascular events in chronic kidney disease (CKD) 3-5 patients. Clin Nephrol 2007; 67: 352-7.
25. Bostom AG, Shemin D, Verhoef P, et al. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study. Arterioscler Thromb Vasc Biol 1997; 17: 2554-8.
26. Boaz M, Matas Z, Biro A, et al. Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis. Kidney Int 1999; 56: 1078-83.
27. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. In-fammation enhances cardiovascular risk and mortality in hemodi-alysis patients. Kidney Int 1999; 55: 648-58.
28. Wahn F, Daniel V, Kronenberg F, Opelz G, Michalk DV, Querfeld U. Impact of apolipoprotein(a) phenotypes on long-term renal transplant survival. J Am Soc Nephrol 2001; 12: 1052-8.
29. Levin A, Thompson CR, Ethier J, et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 1999; 34: 125-34.
30. Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int 2001; 59: 407-14. (Review)
31. Zoccali C, Benedetto FA, Mallamaci F, et al. Infammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients. J Hypertens 2000; 18: 1207-13.
32. Irish A. Cardiovascular disease, fibrinogen and the acute phase response: associations with lipids and blood pressure in patients with chronic renal disease. Atherosclerosis 1998; 137: 133-9.
33. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-41.
34. Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation 1999; 100: 230-5.
35. Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, et al. Association of estimated glomerular fltra-tion rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-81.
36. Tonelli M, Muntner P, Lloyd A, et al. Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study. Ann Intern Med 2011; 154: 12-21.
37. Ridker PM, MacFadyen J, Cressman M, Glynn RJ. Efficacy of ro-suvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justifcation for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial. J Am Coll Cardiol 2010; 55: 1266-73.